Markets

SEPTEMBER 14, 2026 REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

San Diego, California--(Newsfile Corp. - September 5, 2026) - The law firm of Robbins Geller Rudman ...